Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...
Massive Insider Buys at Exor. Management has skin in the game and a 18.2% annualized track-record. Exor is trading 37% below liquidation value. If I notice that a cluster of Insiders is buying ...
Shares sold at 450 euros each, bookrunner says Ferrari bought back 300 million euros of its own shares Exor will retain 20% stake, 30% voting rights in Ferrari The sale will help Exor reduce ...
The Tender Offer will be carried out as part of the €1 billion share buyback program announced by Exor in February 2025. Exor's Board of Directors believes that the current value of Exor provides an ...
Simply sign up to the European companies myFT Digest -- delivered directly to your inbox. The protracted three-way battle to buy PartnerRe ended on Monday when the Bermuda reinsurer accepted a $6.9bn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results